Cocrystal Pharma (COCP) insider buys 10,000 shares via trust
Rhea-AI Filing Summary
Phillip Frost M.D., a director and 10% owner of Cocrystal Pharma, Inc., reported an indirect open-market purchase of 10,000 shares of Common Stock on August 5, 2026 at a weighted average price of $0.9816, with individual trade prices ranging from $0.972 to $0.9898, through Frost Gamma Investments Trust. After this purchase, the trust holds 1,993,551 shares indirectly, while Frost also reports 27,100 shares held directly, including shares issuable upon vesting of restricted stock units. Frost disclaims beneficial ownership of the trust-held securities and of securities owned by OPKO Health, Inc., except to the extent of any pecuniary interest, and the transaction was not reported as pursuant to a Rule 10b5-1 trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 10,000 shares
Net Buy
2 txns
Insider
FROST PHILLIP MD ET AL
Role
Director, 10% Owner
Bought
10,000 shs ($10K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock F1, F2 | 10,000 | $0.9816 | $10K |
| holding | Common Stock F3 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 1,993,551 shares (Indirect, By Frost Gamma Investments Trust);
Common Stock — 27,100 shares (Direct)
Footnotes (3)
- F1. The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions ranging from $0.972 to $0.9898, inclusive. The reporting person undertakes to provide to Cocrystal Pharma, Inc., any security holder of Cocrystal Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares purchased at each separate price within the ranges set forth in the preceding sentence.
- F2. These shares are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole stockholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is the sole stockholder of Frost-Nevada Corporation. The Reporting Person disclaims beneficial ownership of the securities held by Frost Gamma Investments Trust except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F3. Includes shares of common stock issuable upon vesting of restricted stock units.
Key Figures
Shares purchased: 10,000 shares
Weighted average price: $0.9816 per share
Trade price range: $0.972 to $0.9898 per share
+2 more
5 metrics
Shares purchased
10,000 shares
Indirect open-market purchase on August 5, 2026
Weighted average price
$0.9816 per share
Price for 10,000-share purchase on August 5, 2026
Trade price range
$0.972 to $0.9898 per share
Range of individual trades in the August 5, 2026 purchase
Indirect holdings after transaction
1,993,551 shares
Common Stock held indirectly via Frost Gamma Investments Trust
Direct holdings after transaction
27,100 shares
Directly held Common Stock, including shares issuable upon RSU vesting
Key Terms
weighted average price, restricted stock units, beneficial ownership, pecuniary interest, +1 more
5 terms
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
restricted stock units financial
"Includes shares of common stock issuable upon vesting of restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
beneficial ownership regulatory
"The Reporting Person disclaims beneficial ownership of the securities held by Frost Gamma Investments Trust"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"except to the extent of any pecuniary interest therein"
Section 16 regulatory
"for purposes of Section 16 or for any other purpose."
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
Was Phillip Frost’s August 5, 2026 COCP trade made under a Rule 10b5-1 plan?
The August 5, 2026 COCP transaction was not reported as being made under a Rule 10b5-1 trading plan. The Rule 10b5-1 checkbox for this report is unchecked, and no footnote indicates that a pre-arranged trading plan governed the trades.